A key role for corticotropin-releasing factor in alcohol dependence

Trends in Neurosciences

Volumn 30, Issue 8, 2007, Pages 399-406

  Heilig, Markus ^a   Koob, George F ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; NALTREXONE; OPIATE ANTAGONIST;

ALCOHOLISM; AMYGDALOID NUCLEUS; CORTICOTROPIN RELEASE; EMOTIONALITY; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REINFORCEMENT; REVIEW; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; AFFECT; ALCOHOL-RELATED DISORDERS; AMYGDALA; ANIMALS; BEHAVIOR, ADDICTIVE; CORTICOTROPIN-RELEASING HORMONE; ETHANOL; HUMANS; REWARD;

EID: 34447644753     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2007.06.006     Document Type: Review

References (71)

1. Ezzati M., et al. Selected major risk factors and global and regional burden of disease. Lancet 360 (2002) 1347-1360
2. Goldman D., et al. The genetics of addictions: uncovering the genes. Nat. Rev. Genet. 6 (2005) 521-532
3. Dackis C., and O'Brien C.P. Neurobiology of addiction: treatment and public policy ramifications. Nat. Neurosci. 8 (2005) 1431-1436
4. Åmark C. A study in alcoholism; clinical, social-psychiatric and genetic investigations. Acta Psychiatr. Neurol. Scand. 70 Supplementum (1951) 1-283
5. McCarty C.A., et al. Continuity of binge and harmful drinking from late adolescence to early adulthood. Pediatrics 114 (2004) 714-719
6. Dawson D.A., et al. Another look at heavy episodic drinking and alcohol use disorders among college and noncollege youth. J. Stud. Alcohol 65 (2004) 477-488
7. Heinz A., et al. Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol Alcohol. 38 (2003) 35-39
8. Sterling P., and Eyer J. Allostasis: a new paradigm to explain arousal pathology. In: Fisher R., and Reason J. (Eds). Handbook of Life Stress, Cognition and Health (1988), John Wiley & Sons 629-649
9. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22 (2000) 108-124
10. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
11. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8 (2005) 1442-1444
12. Heilig M., and Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 111 (2006) 855-876
13. Egli M. Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?. Addict. Biol. 10 (2005) 309-319
14. Rogers J., et al. Long-term ethanol administration methods for rats: advantages of inhalation over intubation or liquid diets. Behav. Neural Biol. 27 (1979) 466-486
15. Roberts A.J., et al. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22 (2000) 581-594
16. Rimondini R., et al. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J. 16 (2002) 27-35
17. O'Dell L.E., et al. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcohol. Clin. Exp. Res. 28 (2004) 1676-1682
18. Breese G.R., et al. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 30 (2005) 1662-1669
19. Breese G.R., et al. Conceptual framework for the etiology of alcoholism: a 'kindling'/stress hypothesis. Psychopharmacology (Berl.) 178 (2005) 367-380
20. Becker H.C., and Lopez M.F. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol. Clin. Exp. Res. 28 (2004) 1829-1838
21. De Witte P., et al. Alcohol and withdrawal: from animal research to clinical issues. Neurosci. Biobehav. Rev. 27 (2003) 189-197
22. Rimondini R., et al. A temporal threshold for induction of persistent alcohol preference: behavioral evidence in a rat model of intermittent intoxication. J. Stud. Alcohol 64 (2003) 445-449
23. Vale W., et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
24. Swanson L.W., et al. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36 (1983) 165-186
25. Heinrichs S.C., and Koob G.F. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J. Pharmacol. Exp. Ther. 311 (2004) 427-440
26. Dautzenberg F.M., and Hauger R.L. The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23 (2002) 71-77
27. Muller M.B., and Wurst W. Getting closer to affective disorders: the role of CRH receptor systems. Trends Mol. Med. 10 (2004) 409-415
28. Makino S., et al. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol. Biochem. Behav. 73 (2002) 147-158
29. 1 receptor antagonist. II. Characterization in rodent models of stress-related disorders. J. Pharmacol. Exp. Ther. 301 (2002) 333-345
30. 1 receptor antagonist. I. Biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther. 301 (2002) 322-332
31. Hokfelt T., et al. Chemical anatomy of the brain. Science 225 (1984) 1326-1334
32. Baldwin H.A., et al. CRF antagonist reverses the 'anxiogenic' response to ethanol withdrawal in the rat. Psychopharmacology (Berl.) 103 (1991) 227-232
33. Rassnick S., et al. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605 (1993) 25-32
34. Merlo Pich E., et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15 (1995) 5439-5447
35. Olive M.F., et al. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 72 (2002) 213-220
36. Valdez G.R., et al. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 29 (2003) 55-60
37. Sommer, W.H. et al. Up-regulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol. Psychiatry (in press)
38. Overstreet D.H., et al. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol. Clin. Exp. Res. 26 (2002) 1259-1268
39. Knapp D.J., et al. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 32 (2004) 101-111
40. Overstreet D.H., et al. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 77 (2004) 405-413
41. Funk C.K., et al. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 61 (2007) 78-86
42. Funk C.K., et al. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26 (2006) 11324-11332
43. Valdez G.R., et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 26 (2002) 1494-1501
44. Gehlert D.R., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethy l- imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J. Neurosci. 27 (2007) 2718-2726
45. Brownell K.D., et al. Understanding and preventing relapse. Am. Psychol. 41 (1986) 765-782
46. Shaham Y., et al. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl.) 168 (2003) 3-20
47. Le A.D., et al. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl.) 150 (2000) 317-324
48. Liu X., and Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 22 (2002) 7856-7861
49. Wang B., et al. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J. Neurosci. 25 (2005) 5389-5396
50. McFarland K., et al. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24 (2004) 1551-1560
51. Le A.D., et al. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl.) 179 (2005) 366-373
52. Funk D., et al. Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 138 (2006) 235-243
53. Le A.D., et al. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 22 (2002) 7844-7849
54. Zorrilla E.P., et al. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl.) 158 (2001) 374-381
55. Ciccocioppo R., et al. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict. Biol. 11 (2006) 339-355
56. Treutlein J., et al. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol. Psychiatry 11 (2006) 594-602
57. Hansson A.C., et al. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15236-15241
58. Hansson A.C., et al. Region-specific down regulation of Crhr1 gene expression in alcohol preferring msP rats following ad lib access to alcohol. Addict. Biol. 12 (2007) 30-34
59. Sillaber I., et al. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 296 (2002) 931-933
60. Flatscher-Bader T., and Wilce P.A. Chronic smoking and alcoholism change expression of selective genes in the human prefrontal cortex. Alcohol. Clin. Exp. Res. 30 (2006) 908-915
61. Rothstein J.D., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996) 675-686
62. Swanson C.J., et al. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev. Drug Discov. 4 (2005) 131-144
63. Thorsell A., et al. NPY in alcoholism and psychiatric disorders. EXS 95 (2006) 183-192
64. Rimondini R., et al. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci. Lett. 375 (2005) 129-133
65. Thorsell A., et al. Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure. Behav. Brain Res. 161 (2005) 133-140
66. Thorsell A., et al. Effects of neuropeptide Y on appetitive and consummatory behaviors associated with alcohol drinking in wistar rats with a history of ethanol exposure. Alcohol. Clin. Exp. Res. 29 (2005) 584-590
67. Kelley S.P., et al. Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration. Peptides 22 (2001) 515-522
68. Heilig M., et al. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17 (1994) 80-85
69. Sarnyai Z., et al. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53 (2001) 209-243
70. Katner S.N., et al. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20 (1999) 471-479
71. Le A.D., et al. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology (Berl.) 135 (1998) 169-174